Blood Test for Breast Cancer Using DNA Methylation
Author Information
Author(s): Radpour Ramin, Barekati Zeinab, Kohler Corina, Lv Qing, Bürki Nicole, Diesch Claude, Bitzer Johannes, Zheng Hong, Schmid Seraina, Zhong Xiao Yan
Primary Institution: University of Basel, Basel, Switzerland
Hypothesis
Can DNA methylation patterns in blood be used as biomarkers for breast cancer diagnosis?
Conclusion
The study suggests that a panel of tumor suppressor genes can be used to develop a blood-based test for breast cancer with high sensitivity and specificity.
Supporting Evidence
- The study found significantly higher levels of circulating methylated DNA from tumor suppressor genes in breast cancer patients compared to normal controls.
- Using a panel of eight genes, the test achieved over 90% sensitivity and specificity in distinguishing between tumor and normal samples.
- Hypermethylation patterns were consistent between tumor tissue and serum samples.
Takeaway
Doctors can look at DNA from your blood to help find out if you have breast cancer. This test is really good at telling the difference between sick and healthy people.
Methodology
The study analyzed DNA methylation of 10 candidate genes in two cohorts using high-throughput MALDI-TOF mass spectrometry.
Limitations
The study's findings need further validation with larger sample sizes.
Participant Demographics
The first cohort included 36 plasma samples from breast cancer patients and 30 from healthy women; the second cohort included 60 triple matched samples from 20 breast cancer patients.
Statistical Information
P-Value
p<0.01
Confidence Interval
0.720–0.928
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website